{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:38:42Z","timestamp":1774953522607,"version":"3.50.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Osteoporosis has be reported to be a complication of active antiretroviral therapy of HIV infection. We studied 148 HIV-infected men stratified according to their treatment. Our data show that these patients have an average 9% decreased BMD, irrespective of their treatment. Low body mass index and high resorption markers were associated with low bone density.<\/jats:p>\n               <jats:p>Introduction: Osteoporosis has been reported in HIV-infected (HIV+) patients, and it has been suggested that it may be linked to protease-inhibitor treatments (PI).<\/jats:p>\n               <jats:p>Materials and Methods: To assess this risk and to investigate its putative link with treatments, we compared the bone density of HIV+ men, who were either receiving treatment (including PI [PI+], n = 49; without PI [PI\u2212], n = 51) or untreated (UT, n = 48). We included 81 age-matched control HIV-negative (HIV\u2212) males (age, 40 \u00b1 8 years).<\/jats:p>\n               <jats:p>Results: BMD adjusted for age (Z-score) was lower in the HIV+ patients at the lumbar spine (HIV+: \u22121.08 \u00b1 1.21, HIV\u2212: \u22120.06 \u00b1 1.26, p &amp;lt; 0.001) and the femoral neck (HIV+: \u22120.39 \u00b1 1.05, HIV\u2212: 0.25 \u00b1 0.87, p &amp;lt; 0.001). The prevalence of osteoporosis was 16% in HIV+ and 4% in HIV\u2212 subjects (p &amp;lt; 0.01). In the HIV+ subjects, the Z-score was correlated only to body mass index (r = 0.27 at lumbar spine and 0.35 at femoral neck). Untreated HIV+ patients had a negative Z-score (\u22120.82 \u00b1 1.15 for the lumbar spine), which was not different from the one of treated HIV+ patients. In the PI+ and PI\u2212 groups, the Z-score did not depend on the presence of lipodystrophy or the proportion of fat in the abdomen and legs measured by DXA. Markers of bone remodeling were measured in the 132 HIV+ and 35 HIV\u2212 subjects. Compared with controls, HIV+ patients had lower bone alkaline phosphatase and higher urinary cross-laps\/Cr, which was negatively correlated with the Z-score at both the femoral neck (r = \u22120.22) and lumbar spine (r = \u22120.21). TNF\u03b1 was increased in untreated compared with treated HIV+ subjects and was not correlated to the Z-score.<\/jats:p>\n               <jats:p>Conclusion: Our cross-sectional study does not show any deleterious effect of the treatment but does indicate a decrease in bone density in HIV+ patients irrespective of the treatment. This low bone density is in part related to the low body weight and is associated with increased bone resorption.<\/jats:p>","DOI":"10.1359\/jbmr.0301246","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T07:01:13Z","timestamp":1146121273000},"page":"402-409","source":"Crossref","is-referenced-by-count":132,"title":["BMD Is Reduced in HIV-Infected Men Irrespective of Treatment"],"prefix":"10.1093","volume":"19","author":[{"given":"C","family":"Amiel","sequence":"first","affiliation":[{"name":"Department of Infectious Disease, H\u00f4pital Tenon, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Ostertag","sequence":"additional","affiliation":[{"name":"INSERM U349, Department of Rheumatology and Biochemistry, H\u00f4pital Lariboisi\u00e8re, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Slama","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, H\u00f4pital Tenon, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Baudoin","sequence":"additional","affiliation":[{"name":"INSERM U349, Department of Rheumatology and Biochemistry, H\u00f4pital Lariboisi\u00e8re, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"N'Guyen","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, H\u00f4pital Tenon, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Lajeunie","sequence":"additional","affiliation":[{"name":"INSERM U349, Department of Rheumatology and Biochemistry, H\u00f4pital Lariboisi\u00e8re, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Neit-Ngeilh","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, H\u00f4pital Tenon, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Rozenbaum","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, H\u00f4pital Tenon, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MC","family":"De Vernejoul","sequence":"additional","affiliation":[{"name":"INSERM U349, Department of Rheumatology and Biochemistry, H\u00f4pital Lariboisi\u00e8re, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024013019213289500_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"2024013019213289500_bib2","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"2024013019213289500_bib3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0140-6736(05)70281-6","article-title":"Abnormal fat accumulation in patients with HIV-1 infection","volume":"351","author":"Lipsky","year":"1998","journal-title":"Lancet"},{"key":"2024013019213289500_bib4","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","article-title":"Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy","volume":"14","author":"Tebas","year":"2000","journal-title":"AIDS"},{"key":"2024013019213289500_bib5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0889-8529(05)70009-8","article-title":"Osteoporosis in men","volume":"27","author":"Orwoll","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2024013019213289500_bib6","first-page":"3431","article-title":"Osteoporosis in men","volume":"84","author":"Bilezikian","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019213289500_bib7","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/00002030-200109070-00019","article-title":"Reduced bone mineral density in HIV-positive individuals","volume":"15","author":"Moore","year":"2001","journal-title":"AIDS"},{"key":"2024013019213289500_bib8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/00002030-200105250-00005","article-title":"Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy","volume":"15","author":"Huang","year":"2001","journal-title":"AIDS"},{"key":"2024013019213289500_bib9","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019213289500_bib10","volume-title":"Lme and nlme: Mixed-Effects Methods and Classes for S and S-PLUS Version 30 Bell Labs","author":"Pinheiro","year":"1999"},{"key":"2024013019213289500_bib11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00002030-200104130-00005","article-title":"Asteopenia in HIV-infected men: Association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy","volume":"15","author":"Carr","year":"2001","journal-title":"AIDS"},{"key":"2024013019213289500_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00002030-200101050-00025","article-title":"Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy","volume":"15","author":"Guaraldi","year":"2001","journal-title":"AIDS"},{"key":"2024013019213289500_bib13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/ajcn\/74.5.679","article-title":"Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women","volume":"74","author":"McDermott","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"2024013019213289500_bib14","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00002030-200107060-00009","article-title":"Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir","volume":"15","author":"Nolan","year":"2001","journal-title":"AIDS"},{"key":"2024013019213289500_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/367569","article-title":"Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals","volume":"36","author":"Mondy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2024013019213289500_bib16","first-page":"145","article-title":"Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: Indication of normalization of the bone-remodeling process during highly active antiretroviral therapy","volume":"84","author":"Aukrust","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019213289500_bib17","doi-asserted-by":"crossref","first-page":"19247","DOI":"10.1074\/jbc.C200069200","article-title":"Select HIV protease inhibitors alter bone and fat metabolism ex vivo","volume":"277","author":"Jain","year":"2002","journal-title":"J Biol Chem"},{"key":"2024013019213289500_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2001.16.1.2","article-title":"Bone and mineral metabolism in human immunodeficiency virus infection","volume":"16","author":"Kuhne","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2024013019213289500_bib19","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1097\/00002030-199911120-00007","article-title":"Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: Correlation between dyslipidaemia and steroid hormone alterations","volume":"13","author":"Christeff","year":"1999","journal-title":"AIDS"},{"key":"2024013019213289500_bib20","first-page":"227","article-title":"The insulin-like growth factor system in human immunodeficiency virus infection: Relations to immunological parameters, disease progression, and antiretroviral therapy","volume":"86","author":"Helle","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019213289500_bib21","first-page":"2576","article-title":"Normal growth hormone secretory reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-I","volume":"83","author":"Kurland","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019213289500_bib22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/0952-7915(93)90045-T","article-title":"Immunobiological aspects of HIV treatment","volume":"5","author":"Dalgleish","year":"1993","journal-title":"Curr Opin Immunol"},{"key":"2024013019213289500_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/384529a0","article-title":"Host factors and the pathogenesis of HIV-induced disease","volume":"384","author":"Fauci","year":"1996","journal-title":"Nature"},{"key":"2024013019213289500_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00003086-199603000-00003","article-title":"Cytokines and skeletal physiology","volume":"324","author":"Goldring","year":"1996","journal-title":"Clin Orthop"},{"key":"2024013019213289500_bib25","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jcem.83.5.4808","article-title":"Increased bone resorbing activity of peripheral monocyte culture supernatants in elderly women","volume":"83","author":"Cohen-Solal","year":"1998","journal-title":"J Clin Endocr Metab"},{"issue":"Suppl","key":"2024013019213289500_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/(SICI)1097-4644(1998)72:30\/31+<55::AID-JCB9>3.0.CO;2-R","article-title":"Control of bone formation and resorption: Biological and clinical perspective","volume":"31","author":"Rodan","year":"1998","journal-title":"J Cell Biochem"},{"key":"2024013019213289500_bib27","first-page":"2020","article-title":"Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome","volume":"86","author":"Fairfield","year":"2001","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2FJBMR.0301246","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/19\/3\/402\/56474394\/5650190308.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/19\/3\/402\/56474394\/5650190308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:06:13Z","timestamp":1710342373000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/19\/3\/402-409\/7592757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,1]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[2004,3,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.0301246","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2004,3,1]]},"published":{"date-parts":[[2004,3,1]]}}}